In this week’s blog, IMF Chairman of the Board and Chief Scientific Officer Dr. Brian G.M. Durie provides several tips to starting off the new year with better health. He recommends three new books: one about living to a hundred through the Blue Zone diet, another about the new science of breathing properly, and a third one on de-stressing by enjoying the company of birds in your backyard. Dr. Durie advises to keep your mind away from the troubles of the day and to focus on improving your overall health in 2023. READ THE BLOG.

Imagine being served up content that met you where you are in your patient journey. You visit the IMF website and learn what clinical trials you qualify for, or which myeloma experts can best help you in your region. To better serve its patient community, the International Myeloma Foundation (IMF) has deployed Data Lakes for Nonprofits – powered by Amazon Web Services (AWS) and offered by AWS and Salesforce. The goal is to create a more patient-focused digital ecosystem that meets patients, donors, and other IMF community members where they are. Learn about this exciting new partnership now. LEARN MORE.

Back in person for the first time since 2019, the International Myeloma Foundation (IMF) is excited to announce that the 2023 Boca Raton Patient and Family Seminar is taking place on March 17-18, 2023, in Boca Raton, Florida. In the coming days, the IMF will announce our expert speaker lineup for the upcoming Boca Raton Patient and Family Seminar. We promise you will not want to miss this unique opportunity to hear from top myeloma experts from around the world. In-person seating is limited; register today before attendance is full. REGISTER NOW.

The IMF will host a Virtual Regional Community Workshop for the Midwest region on Wednesday, February 15, 2023, at 5:30 p.m. CST / 6:30 p.m. EST. Jonathan Kaufman, MD (Winship Cancer Institute, Emory University— Atlanta) will review multiple myeloma basics, common symptoms and side effects, advances in diagnosis, stages of myeloma treatment, induction therapy, and transplant. Rafat Abonour, MD (Indiana University – Indianapolis) will talk about types of relapsed disease, what doctors consider when selecting a treatment regimen, relapsed/refractory treatment options, how doctors treat triple and penta-class refractory myeloma, and clinical trials. IMF Nurse Leadership Board member Daniel Verina, DNP, ACNP-BC (Mount Sinai Medical Center Hematology – New York) will discuss how patients can manage the side effects of myeloma and its treatments. After each presentation with the experts, attendees will have ample time to ask questions. REGISTER NOW.

The IMF continues to keep patients at the center of everything we do. With this in mind, we invite you to explore the results the IMF had in our 2022 Impact Report, available to download now.  When you click on the burgundy words within the document, you can learn more on each topic. READ NOW.

The IMF wants YOU to raise myeloma awareness on a global scale by sharing your #MYelomaSTORY. When you share your story, you raise awareness of myeloma; create a stronger and more connected community; help doctors, researchers, and other healthcare professionals understand the importance of their work; and accelerate the pathway to a cure. 

Participating is simple: 1) Take a video of yourself answering the question: "In ONE WORD, my myeloma story is...” 2) Upload your video using the submission form linked here: SUBMIT MY VIDEO.